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Abstract
Chronic pain is a significant burden in all societies. The myofascial origins of 
chronic pain are often unrecognized but play a major role in chronic pain genera-
tion. Myofascial release has been shown to be effective and can augment the limited 
number of therapeutic tools available to manage chronic pain. However, there is 
no standardized approach that allows for comparative analysis of this technique. 
myoActivation® is a unique therapeutic system, which targets active myofascial 
trigger points, fascia in tension, and scars in patients with chronic pain. Targets 
for intervention are determined through obtaining a history of lifetime trauma 
and a structured, reproducible posture, and movement assessment. Catenated 
cycles of movement tests, palpation, and needling are used to achieve the goal of 
pain resolution through restoration of soft tissue integrity. This chapter describes 
the distinctive features of myoActivation from the important key elements of the 
patient’s clinical history, through to the aftercare instructions. Relevant evidence 
for each component will be presented. Case studies will be used to illustrate some 
important concepts and the effectiveness of myoActivation. This chapter is relevant 
to all clinicians that manage people living with chronic pain.
Keywords: pain, chronic pain, paediatric pain, mobility dysfunction, fascia, 
myofascial trigger points, timeline of lifetime trauma, physical trauma, scars, 
palpation, catenated cycles, structured assessment, non-pharmaceutical,  
pain management
1. Introduction
Pain is defined by the International Association for the Study of Pain (IASP) 
as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage” [1]. Pain is a highly 
subjective sensation influenced by: degree of tissue damage, response to medica-
tions, diet, age, sex, genetics, cultural background, and psychosocial factors 
including attention, emotion, cognition, beliefs, expectations, and socioeconomic 
status (Figure 1).
“The good physician treats the disease; the great physician treats the patient who 
has the disease”.
Sir William Osler, 1849–1919
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Pain is a sensory output from the brain when the brain is on alert. In acute pain, 
this sensory output is important to protect the organism from further harm during 
the healing phase, and, is usually associated with a nociceptive stimulus.
Chronic pain is quite different; although it is typically considered to refer to pain 
lasting longer than 3 months, such a time limit seems to be reductive, and it more 
properly refers to “pain that extends beyond the expected period of healing” [2]. 
The overall prevalence of chronic pain conditions is estimated to be in the order of 
35–51% of the adult population [3] and the incidence of widespread chronic pain 
estimated to be 10–15% [4]. Chronic pain occurs across the lifespan, including 
children [5] and the elderly [6]. The frequency of visits to physicians, emergency 
departments, and other healthcare providers is significantly increased in the pres-
ence of chronic pain [7]. Currently, the burden of chronic pain has a huge impact on 
quality of life in the lives of people with chronic pain [8, 9]. The economic burden 
of chronic pain in terms of healthcare costs is substantial, but pales in significance 
compared to the costs of lost productivity due to job redundancy and sick days [9].
1.1 Background
Chronic pain is a complex biopsychosocial phenomenon that requires a multidis-
ciplinary approach to management. This usually includes return to physical function 
[10], graded return to work/school, medications to help with pain, mood and sleep, 
as well as non-pharmacological techniques to address the psychosocial components 
of pain [9, 11, 12]. The weakest link in this therapeutic process is the pharmacological 
approach, especially the overreliance on the use of opioid medications. The prescrip-
tion of opioids for chronic non-cancer pain increased fourfold in USA from the early 
1990s up to 2011 [13, 14]. Opioids contribute only modest relief of chronic pain. 
They have limited effects on improvement in function but cause significant opioid 
side effects [15]. Opioid substance abuse and opioid-related death are major issues 
associated with prescription of opioids for chronic pain. Review of opioid-related 
deaths demonstrates that the majority had a diagnosis of chronic pain in their last 
year of life [16]. Prescription of opioid medications has gradually decreased since 
2011, but the opioid-related overdose death rate continues to rise exponentially [17]. 
This current opioid crisis constitutes a critical public health issue in USA and Canada 
[13]. Even though the prescription of opioid drugs does not appear to be causally 
Figure 1. 
The biopsychosocial contributors to chronic pain.
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related to overdose deaths, it is clear that their prescription is one pathway to long-
term use: 5.3% of opioid naïve adults prescribed opioids will still be on opioids 1 year 
later [18]. Increased numbers of opioids prescribed on the first prescription predicts 
a lower likelihood of opioid discontinuation [18]. It is notable that 20% of children 
with chronic musculoskeletal pain are prescribed opioids [19].
Up to 22.5% of chronic pain patients develop their chronic pain condition after 
surgery [20]. Persistent postsurgical pain (PPSP) represents a significant clinical 
problem, occurring after 10–50% of surgeries and resulting in severe chronic pain in 
2–10% of these patients [21]. PPSP is considered to be primarily neuropathic (nerve 
damage during surgery) where the incidence depends on various perioperative 
factors, including genetic predisposition, preoperative anxiety, depression, preop-
erative pain, the extent of the surgical insult, surgical technique, length of surgery, 
and the quality of acute postoperative pain management [21, 22]. In 27% of patients 
receiving chronic opioid therapy, treatment for pain after surgery was the reason for 
opioid initiation [23]. There is 5.9–6.5% incidence of new persistent opioid use after 
surgery, not only after major surgery but also after minor surgical procedures [24].
Multiple traumas have a cumulative effect on chronic pain [25], independent of 
post-traumatic distress disorder symptoms [26]. Increased risk of physical ill-health 
is associated with exposure to a single traumatic event but accrues as more events 
are experienced [27]. It is not clear what characteristics of past traumatic experi-
ences (type, duration, severity, earlier onset) influence the strength of the relation-
ship between accumulative traumatic events and subsequent medical conditions 
[28]. Contemporary clinical history taking often neglects distant trauma as signifi-
cant contributor to a chronic pain issue presenting many years later.
Chronic pain occurs from various combined sources, including nociceptive, 
inflammatory, neuropathic, myofascial, as well as peripheral and central sensitisation. 
Musculoskeletal (MSK) conditions are a predominant source of chronic pain worldwide 
[29]. The clinical and etiological characteristics of myofascial pain have been poorly 
investigated. The subsequent lack of evidence has led to undertraining of health care pro-
fessionals, and poor recognition of the clinical importance of myofascial pain syndromes  
(a group of painful conditions that affect muscles and connective tissues) [30, 31].
Myofascial pain syndromes are characterized by pain, myofascial trigger points 
(MTPs) (palpable nodules in taut bands of muscle fibres), referred pain, coupled pain, 
and autonomic changes. Chemical changes within the muscle may also lead to periph-
eral sensitization. MTPs can generate continual nociceptive traffic to induce central 
sensitization, cortical re-organization, and alterations in descending inhibitory pain 
pathways [32–36]. MTPs are associated with muscles in sustained contraction caus-
ing limited movement across joints [37]. The MSK system is symmetrical; a muscle in 
sustained contraction on one side will cause compensatory MSK issues to occur on the 
other. Therefore, a patient with MSK imbalance may proceed to have many different 
myofascial areas affected from one previous injury or insult. It is important to note that 
palpable pain points (PPPs) exist, not only in skeletal muscle, but also in fascia and scars.
One of the components of MSK pain is coupled pain, which is distinct from 
referred pain. Referred pain is pain perceived at a location other than the site of the 
painful stimulus or origin of pain. Referred pain results from neuronal stimula-
tion within a dermatome (a localized area of skin that has its sensation via a single 
nerve, from a single nerve root of the spinal cord). In coupled pain, the source of 
pain is distant, not dermatomal, from the localized area of pain. Examples include 
shoulder pain or knee pain originating from strained ipsilateral external oblique 
muscle, or lower quadrant abdominal pain originating from an ipsilateral quadratus 
lumborum muscle in sustained contraction [38–40]. This distant site has no direct 
muscular or neurological connection, yet the coupled pain is resolved by restoration 
of the originating tissue to a normal anatomical state [41].
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Myofascial release can be effective but lacks a standardized approach and 
therefore prevents good quality comparative analysis.
Given the societal burden of pain and overuse of opioid medications, it is clear 
that clinicians require a different and more effective model of assessment and treat-
ment that minimizes opioid prescriptions and realizes myofascial components of 
pain [19, 42]. This chapter will outline the importance of surgical scars and myo-
fascial dysfunction as other important determinants of a chronic pain presentation. 
myoActivation is one component of the multimodal approach to patient care that 
helps to accurately determine and treat the myofascial components of chronic pain 
without the need for prescription medications.
1.2 Aim
The aim of this chapter is to describe a system of standardized assessment 
and treatment for chronic pain called myoActivation®. We will comprehensively 
describe the distinctive features of this system, from the patient’s clinical history 
to after-care management. We will present evidence for the scientific background 
and individual component techniques of myoActivation, where it exists, and outline 
future approaches for gathering evidence of the effectiveness and efficiency of the 
myoActivation treatment programme as a whole.
This chapter is practically orientated to enable clinicians to understand what 
myoActivation means. Three case studies will illustrate the effectiveness of myoAc-
tivation. Then, the next steps in the development and evaluation of myoActivation 
will be discussed. Barriers to integrative care (including alternative therapies) are 
awareness, availability, accessibility, and affordability [43]; these will be discussed 
in relation to myoActivation as well as the need to establish a firm basis of clinical 
evidence for this treatment system.
Finally, we must emphasize that myoActivation should be seen as one component 
of multidisciplinary care, i.e., part of a multimodal approach to care, which includes 
focus on eventual return to physical function and work/school, improving recov-
ery from opioid dependency, weaning prescription drug use as well treating the 
psychosocial components of pain.
1.3 myoActivation overview
myoActivation is a unique structured system of assessment and treatment 
designed to reduce myofascial components of chronic pain. A key principle of 
myoActivation is to understand that the site of pain is often not the source of pain 
[38–41, 44]. For example, spasm of the quadratus lumborum muscle mimics 
appendicitis and low back pain may originate from the abdominal wall musculature 
[38, 39, 45]. Myofascial pain is characterised by the presence of myofascial trigger 
points. Myofascial trigger points develop in response to many different insults such 
as trauma, injury, surgery, repetitive microtrauma, poor posture, muscle overuse, 
or overload [46, 47]. Myofascial trigger points that cause pain can originate in scars, 
skeletal muscle, and/or fascia.
The myoActivation assessment is distinguished by recognition of the importance 
of lifetime trauma and the mechanisms of any injuries identified. Postural observa-
tions during systematized, ordered, movement tests identify the true origin of pain 
in soft tissues. The most painful or restricted movement on core tests distinguishes 
the most important tissues to treat first. Careful inspection and palpation of these 
tissues identifies the myofascial source of pain. Treatment entails refined trigger point 
injections, using micro-aliquots of physiological saline, to restore anatomic integrity 
to injured tissues. Fine gauge hypodermic needles are inserted into trigger points 
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that compromise function of muscle, ligament, tendon, subcutaneous fascia, scar 
tissue, and the peripheral nerves of the skin. After each individual myofascial area is 
treated, movement tests are repeated to demonstrate immediate change and direct 
the clinician to the next most important target area. Several cycles occur during each 
myoActivation session. The purpose of these catenated cycles (see Figure 6) is to help 
unravel multiple sources that contribute to the full myofascial pain presentation.
Immediate treatment responses occur, which include reduction in pain, increased 
flexibility, and improved fluidity of movement. After-care instructions require the 
patient to change posture frequently but to refrain from exertional activity for 5 days 
following every myoActivation session. To understand how this technique might be 
useful in everyday care of patients with chronic pain, it is important to understand 
the essential components of myofascial pain (skeletal muscle in sustained contrac-
tion, scars, fascial lines of tension, and the interstitial space).
2. Scientific background
2.1 Skeletal muscle in sustained contraction
Myofascial pain syndrome is characterized by multisite pain, referred pain, 
coupled pain, and peripheral and central sensitisations. A component of myofas-
cial pain is due to MTPs associated with muscles in sustained contraction causing 
limitation of movement across joints [37]. The mechanisms of myofascial pain have 
been reviewed by Jafri [31] and Shah et al. [48].
A 2007 review identified 19 different descriptions of diagnostic criteria for myo-
fascial trigger points and associated pain but found lack of consensus or standard 
definition [49].
A trigger point is a hyperirritable spot in fascia or surrounding skeletal muscle. 
Muscular trigger points are associated with palpable nodules in taut bands of 
muscle fibres. Compression of a trigger point may elicit local tenderness, referred 
pain, coupled pain, autonomic symptoms, or a local twitch response. The local 
twitch response (LTR) is recognized as a spinal reflex [50]. An LTR when the MTP is 
needled or activated is considered a positive response to intervention [51].
Microdialysis techniques demonstrate unique biochemical changes in the region 
of trigger points, which include low pH, increased concentrations of bradykinin, 
calcitonin gene-related peptide, substance P, tumour necrosis factor (TNF), inter-
leukins, serotonin, and norepinephrine. These are also associated with decreased 
local blood flow, reduced oxygen content, and increased reactive oxygen species. 
These nociceptive neuropeptides and inflammatory markers may be the source of 
peripheral nociception potentially initiating and maintaining central sensitization 
in myofascial pain syndrome [48, 52, 53].
The veracity of myofascial trigger points representing true pathologic entities 
have been questioned and debated [54]. However, leading experts in myofascial 
techniques consider this to be a biased view [55].
A systematic MSK exam can distinguish patients with MTPs and chronic pain 
from subjects with no pain [56]. One of the main problems with medical com-
munity acceptance of MTPs has been the lack of objective imaging techniques to 
corroborate examination findings and to assess treatment outcomes [57]. Imaging 
techniques that have been reported to establish the presence of muscle MTPs 
include: magnetic resonance elastography (MRE) [58], and sonoelastography (SEG) 
(Figure 2) [59]. MRE couples MRI with cyclic shear waves to assess tissue stiff-
ness in myofascial taut bands. Stiffness in taut bands was found to be 50% greater 
than adjacent normal muscle tissue. SEG is a non-invasive method that combines 
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ultrasound with simultaneously applied external vibration to distinguish ultra-
sound colour variance with tissue stiffness. Muscle trigger points identified as 
palpable painful nodules in muscle appear as focal, elliptical shaped, hypoechogenic 
areas. Localized regions of low entropy in symptomatic muscle make the tissue 
macroscopically more heterogeneous than a normal muscle that has relatively uni-
form echotexture. Texture analysis of SEG images can distinguish between painful 
muscle trigger points compared to normal muscle [60, 61].
2.1.1 Muscle activation
Muscle activation is the term used to describe when a muscle in sustained 
contraction is restored to a normal relaxed state, through manipulative therapies or 
needling techniques [62]. When a needling technique is used, there is no difference 
in outcomes between dry needling compared to a liquid injectate (such as lidocaine) 
[63–65]. Muscle activation is associated with reduction in pain, and improved 
flexibility, fluidity and range of movement. There is no consensus on the most 
effective needling techniques for different pain presentations [66]. Elicitation of an 
LTR has classically been required for effective muscle activation [51]. Recent work 
disputes that an LTR is necessary, but acknowledges more research is required [67]. 
Decreased spontaneous electrical activity and acetylcholine levels are seen at active 
myofascial trigger points after dry needling in rats [68].
Vascular, chemical, endocrine, neural, and central changes have been dem-
onstrated following needling techniques [68–86]. Interestingly, dry needling also 
appears to be associated with activation of diffuse noxious inhibitory control reduc-
ing pain sensitivity in remote areas to the site of needling. This may be mediated 
through endogenous opioid mechanisms [69, 79–84].
Figure 2. 
Sonography of muscle trigger points (reproduced from Sikdar et al. [59], with permission from Elsevier).
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There are a number of papers in support of the treatment effects, beyond the 
placebo effect, of myofascial release [51, 62, 66, 87–99]. Recent reviews have con-
cluded that better quality studies with standardized interventions and outcomes are 
required to show that myofascial release is an effective intervention in the different 
types of myofascial pain syndromes [100–102]. Despite this, it is clear that myofas-
cial trigger points in skin, fascia, and muscles play an important role in myofascial 
chronic pain presentations.
MTPs and their referral patterns have been eloquently outlined in two volumes 
by Travell and Simons, the first volume for the upper body and the second for the 
lower half of the body [46, 47]. Unfortunately, the publication of these volumes 
did not translate into everyday use in common clinical practice due to a number 
of factors: lack of basic scientific evidence around the aetiology of MTPs, no gold 
standard to identify clinical MTPs, failure to include reproducible assessment and 
examination of MTPs in medical curricula, complexity and diagnostic uncertainty 
from the interaction of more than one MTP on perceived pain, co-occurrence of 
myofascial pain with other disorders such as arthritis, and under-recognition of 
myofascial components in chronic pain [30].
2.2 Skin and the impact of scars
The skin is one of the largest organs in the body and is naturally exposed to 
external stimuli. The skin provides a crucial interface between the body and its 
environment. Skin has different functions and connections, which include connec-
tions to the nervous system through the autonomic nervous system and the locomo-
tor apparatus [103]. The autonomic nervous system constitutes the most important 
connection between the skin, the fascia, and the body [39]. There is continual 
nervous activity, in afferent and efferent mode, between the skin and central 
nervous system to maintain normal homeostasis [39, 104].
There is an independent central emotional connection principally between the 
anterior cingulate cortex and the skin whereby a sympathetic electrical signal can be 
detected in the skin in response to viewing emotionally charged images [105]. The 
skin is also a primary site of small fibre nociceptive endings [106]. It is not difficult 
to speculate that any restriction or impact on the skin, like a scar, will have an impact 
on normal homeostasis and function and hold emotional memory [107, 108].
2.2.1 Scars
When the skin is breached by surgery or injury, a healing process occurs. There 
are four stages to healing: haemostasis, inflammation, proliferation, and remodel-
ling [109]. The remodelling process can take many years and depends on the size 
and nature of the initial wound. During remodelling, type 3 collagen is replaced 
by a stronger type 1 collagen, but not in an ordered manner. Scar tissue is therefore 
strong but not as elastic or flexible as normal tissue [109]. There is an increase in 
nerves and neuropeptides in scar tissue especially hypertrophic scars [110]. In 
patients asked to move actively, electrical activity from a scarred area is higher than 
that from normal tissue in the same patient doing the same movement [111].
Mechanoreceptors and mechanosensitive nociceptors in scarred areas sense 
an alteration from normal and send non-physiological signals creating a patho-
logical reflex arc [39]. Scars can limit normal movement and flexibility of skin, 
and underlying fascia and muscles. For example, an ankle scar will alter the gait 
dynamics through maldistribution of myofascial loads [39]. Patients with scars 
in the abdominal region often have low back pain related to impaired mobility of 
the soft tissues [111, 112]. Scars also have an impact on the distribution of forces 
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that pass through the body following motor vehicle accident (MVA) or injury [39]. 
It has also been suggested that the skin can keep a memory of trauma [107, 108]. 
It is clinically important to consider this when releasing scars associated with a 
particular emotional traumatic event. More research is required to ascertain the 
characteristics of scars that make a significant contribution to a chronic pain 
presentation.
2.2.2 Scar release
Scar release can be achieved with soft tissue mobilization techniques or subci-
sion [107, 111, 113]. Subcision, or microneedling, also known as percutaneous 
collagen induction therapy, is a minimally invasive minor surgical procedure used 
for treating depressed cutaneous scars and wrinkles. Subcision is performed using a 
hypodermic needle inserted through a puncture in the skin surface [114] or derma-
roller. First described in 1995 [115], subcision is a safe, and effective microneedling 
technique used as an aesthetic treatment for several different dermatological 
conditions including scars, rhytids, and striae [114, 116, 117]. Microneedling has 
been shown to induce new collagen formation via platelet and neutrophil release of 
growth factors (TGFβ, platelet derived growth factor, connective tissue growth fac-
tor, connective tissue activating protein), resulting in increased production of col-
lagen, elastin, and glycosaminoglycans [118]. The penetration of a needle through 
skin has been shown to produce other physiological effects such as activation of 
the diffuse noxious inhibitory control systems [119], as well as oxytocin mediated 
peripheral stimulation that inhibits c-fibre discharge to suppress experimental 
behavioural nociception in rats [120].
Currently, the immediate relief of chronic pain following needling of surgical 
scars is limited to case reports [110], and to date, there is insufficient evidence 
to advise on the right time to treat scars after surgery [121]. It will be seen later 
that scar identification and release is an integral part of myoActivation therapy for 
chronic pain.
2.3 Fascial lines of tension
Fascia is described as “dense irregular connective tissue, this tissue surrounds 
and connects every muscle, even the tiniest myofibril, and every single organ of the 
body. It forms a true continuity throughout our whole body” [122, 123]. Fascia has 
traditionally been named according to the region in which it invests, for example, 
thoracolumbar fascia or the iliotibial band. This regional focus is considered to be 
a barrier to the understanding the whole-body interconnectivity of fascia [124]. 
Fascia has both loose and hard fibrous connective tissue components. Loose fascia 
functions to help slide and glide between structures and dense fascia exerts a tensile 
strength in tissues like tendons. Fascia is a complex structure. It contains cells 
(fibroblasts, fasciocytes, myofibroblasts, and telocytes), an extracellular matrix 
(fibres, hyaluronan, and water), nerve elements (proprioceptors, interoceptors, 
and nociceptors), and a system of microchannels (the primovascular system) 
[125]. The contractile elements may contribute to spasms, dysfunction, and pain 
[39]. The fasciocytes produce hyaluronan in response to shear stresses [125]. The 
fascial fibroblasts produce collagen in response to load and stretching. Telocytes 
are probably important in regeneration [126]. Fascia is rich in proprioceptors and 
is an essential integrative component in the locomotor apparatus in assessment and 
control of human posture and movement organization [70]. Fascia has been nick-
named our organ of form [39, 127, 128]. Techniques are currently being developed 
to improve imaging of fascia [129].
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Fascia flexibility is reduced following injury and subsequent immobility; 
this worsens with time and persists even with restoration of movement [130]. 
Stretching, however, reduces thickness of inflammatory lesions, reduces migration 
of neutrophils, and increases concentration of pro-resolving mediators (resolvins) 
[130–134]. It is becoming increasingly clear that fascia has an extremely important 
role to play in molecular biology, functional anatomy, exercise, sport science, repair 
mechanisms, as well as therapeutic modalities [135]. As myoActivation is associated 
with improvements in flexibility and posture, it may well be that one of its effects is 
mediated through fascial mechanisms that enable movement and stretch in a more 
normal anatomical manner.
Biotensegrity is a structural design concept that defines the relationship between 
parts of an organism and the mechanical system that integrates them into a functional 
unit. Humans are described as tension-dependent organisms with myofascial chains 
(Figure 3) [136]. These myofascial chains enable three-dimensional movement while 
continually providing information on balance, stability, and mobility. These chains 
often have an opposing chain to help achieve this balance within the MSK system; for 
example, a posterior myofascial chain pairs with an anterior myofascial chain.
These chains may well help to explain how some pain presentations at distant 
sites, and how myofascial release at distant sites (or opposite sides of the body) 
resolve coupled pain presentations. For example, release of the external oblique 
muscle in sustained contraction will help shoulder pain, release of tension around 
the coccyx will help with neck pain, and/or release of the gastrocnemius/soleus 
muscles in sustained contraction relieves occipital headaches.
2.4 The interstitial space
The interstitial space is a major fluid compartment present in many parts of the 
body. It contains dynamically compressible and distensible sinuses through which 
interstitial fluid flows around the body. It is distinct from, but drains into, the 
lymphatic system. In the average human, up to 15 L of extracellular fluid are nor-
mally housed in the extracellular interstitial space. Interstitial fluid (ISF) and flow 
is an important element of normal tissue function; it bathes and surrounds cells, 
delivers nutrients, and removes metabolic waste [137]. ISF also affects cell signal-
ling, differentiation, remodelling, and migration (giving directional cues to cells) 
[138]. The ISF only flows under conditions of low hydraulic resistance. Blockage of 
these channels in pigs induces hyperalgesia [139]. Release of tight tissues, following 
myoActivation, may help to restore interstitial fluid flow and promote the delivery of 
nutrients and removal of metabolic waste of surrounding tissues.
Figure 3. 
Proposed myofascial chains (reproduced from Wilke et al. [136], with permission from Elsevier).
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More research is required to determine exactly which component (muscle, 
biomechanics, the interstitium, fascia, skin, scars or a combination of these) is 
the major contributor to a chronic pain presentation. The rest of this chapter will 
outline the specific details of the basics of myoActivation, which provides the much-
needed standardized process to correctly identify and treat MTPs in priority order, 
to reduce chronic pain.
3. myoActivation: detailed methods
3.1 Clinical history
As with all chronic pain presentations, it is important to define the clinical prob-
lem, the main site of perceived pain, with its transition over time, as well as the goals 
of treatment for the patient. The focus of a myoActivation history frames the clinical 
problem as the Timeline of Lifetime Trauma (TiLT) and the mechanisms of any 
injuries reported. TiLT requires careful questioning to determine if there have been 
any motor vehicle accidents, fractures, sprains, falls, tailbone injury, major surgery, 
minor surgery, burns, bites, or other scars (e.g., chicken pox or acne). The associated 
healing process of any scar is essential to determine their significance in the pain 
presentation. Infection during a healing process or injuries and scars sustained at a 
young age appear to have significant impact. Recreational and occupational activi-
ties with any associated injuries are important components that need to be asked. 
An important enquiry in the myoActivation history is to ask the patient what they 
consider to be their greatest physical trauma. All these details will be synthesized 
with the subsequent examination findings to help determine the true source of pain.
3.1.1 Investigations
Routine imaging investigations are typically not useful to guide myoActivation 
treatment. However, reports on imaging studies that are provided with a refer-
ral or by the patient should be reviewed and acknowledged in the encounter 
documentation.
3.1.2 Examination
Optimally, the patient has as much skin exposed as possible to allow easier 
evaluation of postural asymmetries, fascial lines of tension, skin creases, and for-
gotten scars. Initially, the patient is asked to identify the location of their perceived 
pain; this point helps direct the examination and is used as an index for subsequent 
treatment effect. Where the patient identifies the perceived origin of pain is rarely 
the tissue that is responsible for the true origin of pain. Then, core Biomechanical 
Assessment and Symmetry Evaluation (BASE) tests are administered (Figure 4). In 
execution of all tests, the clinician is always looking for postural asymmetries.
3.1.3 Balance
The first BASE test is balance. The talus has no muscular attachments and func-
tions as a ball and socket joint around which the skeleton sways depending on the 
distribution of myofascial forces (Figure 5). The centre of the body mass is nor-
mally located anterior to the S2 vertebrae in humans. In an erect stance where there 
is no significant anatomical postural distortion, the centre of mass or gravity will be 
evenly distributed between the feet and over each plantar surface. Therefore, if one 
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foot feels heavier than the other, then there is a shift of the centre of mass or gravity 
towards that side of the body. For example, if weight is perceived to be more on 
the right foot, then there is likely contracted musculature in the right leg “pulling” 
the pelvis to the right and shifting the centre of mass to the right. At this time, the 
patient is asked to report about the distribution of weight on their feet (i.e., right or 
left predominance, towards heels or balls, outside of feet or inside).
At the time of the balance test, the clinician observes postural and position 
between the right and left sides reviewing; feet (e.g., pronated, elevated little toe, 
clawed toes), knees (e.g., hyperextended or hyperflexed), level of the hips, shoulder 
height, any pelvic rotation or tilt, as well as any tilt of the torso or the head. No 
abnormality detected (NAD) should also be documented.
This will be the first time the clinician touches the patient and a verbal consent 
prior to examination of any asymmetries is pertinent.
Figure 4. 
The core biomechanical assessment and symmetry evaluation (BASE) tests.
Figure 5. 
Muscle groups that play a part in balancing the upright skeleton.
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Then, the remaining five core BASE movement tests are performed. These 
tests are used to screen a patient’s body for the true origin of pain. BASE tests 
compartmentalize the true origin of pain to a defined anatomical region. The 
objective in having the patient perform these BASE tests is to identify the most 
painful or restrictive BASE test. The most painful or restrictive BASE test identi-
fies the tissues that are the most significant current contributor to perceived 
pain. There is a simple elegance to this construct in that each test defines a 
specific muscle group or body area. The most painful or restrictive test generally 
provides a clear indication of a starting point for treatment when a patient has 
multiple sites of pain or widespread pain. Even though the individual BASE tests 
are common human movements, the coordinated use of these movement tests to 
define anatomical areas that are the true origin of pain is unique. Administering 
these core BASE tests is quick, reproducible, and consistent. This is the distinc-
tive feature of myoActivation, which will enable future reliable comparative 
research.
• Extension arms raised (EAR): the patient is instructed to bend backwards 
from the hips with his/her arms overhead. Wherever pain is perceived by the 
patient in this posture, the true source of pain originates in the paraspinal 
muscles.
• Extension arms down (EAD): the patient is instructed to arch backwards from 
the hips with his/her arms down. Wherever pain is perceived by the patient in 
this posture, the true source of pain originates in the abdominal muscles.
• Flexion arms down (FAD): the patient is instructed to flex forward with straight 
knees and bend forward to wherever he/she can reach comfortably. The patient 
is questioned in regards specifically to pain in the low back. If pain is perceived 
in the low back in this posture, the true origin of pain is in the medial gluteus 
medius and/or gluteus maximus muscles.
• Squat arms down (SAD): the patient is instructed to squat with their arms 
by their side to where he/she can crouch comfortably. If a patient has a very 
restricted squat, their technique in performing the squat can be improved by 
instructing them to drive their buttocks backwards. A deeper squat will invari-
ably result due to increased pelvic rotation from this manoeuver. Wherever 
pain is perceived by the patient in this posture, the true origin of pain is in the 
quadriceps or calf muscles. If the pain is perceived to be in the upper leg, then 
the quadriceps will be the pain source. If in the lower leg, then the gastrocne-
mius and/or soleus will be the source.
• Squat arms raised (SAR): the patient is instructed to squat with his/her arms 
overhead to where he/she can crouch comfortably. Wherever pain is perceived 
by the patient in this posture, the true origin of pain is in the hamstrings or 
tissues overlying the shin. If the pain is perceived to be in the upper leg, then 
the hamstrings will be the pain source. If the pain report is the lower leg, then 
the medial tibial fascia or soft tissues will be the source.
In performing these core BASE tests, the patient will subconsciously accomplish 
the required movements through accommodation of his/her previous injuries and 
joint restrictions. Deviations from normal symmetry often indicate tissue abnor-
malities. Common postural deviations seen in the performance of core BASE tests 
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include: shifting of the pelvis, lifting of heels or toes, medial deviation of knees, 
shoulder girdle rotation, or asymmetry.
The most restricted or painful of the five movement core BASE tests is the guide 
to a starting point for treatment.
If EAR and EAD or SAD and SAR seem to be equivalent/comparable in causing 
pain or restriction, then the clinician needs to review lateral muscles and tissues. 
For example, comparable EAR and EAD requires testing of the quadratus lumbo-
rum muscles or the three lateral abdominal wall muscles (external oblique, internal 
oblique, and transversus abdominis = triceps abdominis). Comparable SAD and 
SAR requires testing of the tensor fascia lata, vastus lateralis, and the adductor 
muscles (see Table 1 for specific muscles).
Once core BASE tests are complete, there are 55 regional BASE tests used in 
myoActivation to assess pain in the head, face, neck, shoulders, and limbs/extremi-
ties. It is beyond the scope of this chapter to outline all these regional tests.
3.1.4 Palpation
The technique of palpation develops with experience, but is not difficult 
to learn. A rolling motion is used, applied using both thumbs or index finger-
tips simultaneously, on symmetrical tissues to compare right and left sides. 
Differences between right and left may be apparent by the patient’s physical 
reaction, patient’s verbal report, and/or by sensory feedback to the examiner from 
digital pressure.
The goal in palpation of soft tissues is to identify increased density, which is 
painful to the patient and feels different to the clinician when comparing the same 
tissue on the other side. In most instances, when increased density of a soft tissue is 
identified, the patient will express or react to the noticeable increase in discomfort 
or pain associated with palpation of the abnormal tissue. When there are conflicting 
results between the results of BASE tests and findings from palpation, the palpation 
findings are more important as the indicator of the true source of pain. Where a 
patient has a high pain threshold, they may not feel discomfort with palpation. The 
clinician may need to rely on clinical experience to identify the palpable sensation 
of normal tissue density to identify points in the soft tissues that are outside of the 
normal range for distortion with fingertip pressure.
Code BASE test Tissues commonly responsible
BAL Balance
EAR Extension arms raised paraspinal muscles
EAD Extension arms down triceps abdominis/rectus abdominis
FAD Flexion arms down gluteus maximus/gluteus medius
SAD Squat arms down—upper leg pain
Squat arms down—lower leg pain
quadriceps
gastrocnemius/soleus
SAR Squat arms raised—upper leg pain
Squat arms raised—lower leg pain




Comparable EAD/EAR triceps abdominis/quadratus lumborum
Comparable SAD/SAR vastus lateralis/tensor fascia lata  
adductor magnus/adductor longus
Table 1. 
Specific muscles associated with BASE tests.
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3.1.5 Synthesis
At this time, it is helpful to stop and consider the: history of the presenting 
complaint, TiLT, most painful or restrictive BASE tests, identified postural anoma-
lies, and notable findings on palpation. This deliberation serves to connect all these 
factors to discern the relevant myofascial components of the pain presentation. 
Reviewing the cascade of chronological events that have altered the normal ana-
tomical form will help to untangle the multiple sources associated with the present-
ing chronic pain complaint. With experience, pattern recognition will be part of this 
process for common conditions like low back pain.
3.1.6 Consent
Written consent should be obtained after informing the patient of associated risks.
3.1.7 Contraindications to needling treatment
Contraindications to a needling-based treatment include current anticoagulant 
use, immunocompromised state, needle aversion (trypanophobia), or presyncope.
3.1.8 Treatment anticipation
Patients may be anxious due to needle aversion and anticipation of pain from an 
unfamiliar procedure. Offering to provide a trial of a single needle insertion usually 
allows the patient to realize that the actual discomfort is less than the anticipated 
pain of the needling technique. Use of non-pharmacological and pharmacological 
techniques to minimise pain of injection and anxiety are essential [140–143].
3.1.9 Choosing a starting point
Once patients are comfortable with the process, start in the area directed by the 
most painful or restricted core BASE test. In anxious patients, consider an easily 
tolerated point first. This may be a treatment area that they cannot visualize or a 
less sensitive body area such as the gluteus medius. In patients who seem skeptical 
or uncertain, begin treatment closer to their perceived source of pain. Alternatively, 
start at a site that is guaranteed to make a significant difference in pain and/or 
flexibility, such as releasing any scar that is in a tissue area directed by the most 
restrictive or painful core BASE test, i.e., considered to have some association with 
the presenting problem.
3.1.10 Scars
Scars have significant biomechanical consequences in movement and in the 
transmission of forces following a subsequent injury. Abdominal incisions are 
major contributors to pain, pain at distant site, and disturbances in function of 
internal organs [144, 145]. Inspection of scars for guttering or tethering with 
movements helps to determine their significance. Scars with a very high potential 
of significance are associated with Caesarean-section procedures, surgical drains, 
bone grafts, burns, fasciotomies, chicken pox, and penetrating wounds. Scars with 
moderate potential of significance include any incisional or excisional surgical scar, 
especially in the feet. Other important scars include immunization scars, or scars 
from glass cuts, animal bites, and cystic acne.
Scars can be released by a series of needle insertions through scar tissue. 
Release of normal skin adjacent to the scar and palpably dense myofascial tissues 
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surrounding the scar will also contribute to reduction of scar-related tension. Wide 
scars can be released in a zigzag pattern of needle insertions through the scar tissue. 
Release of myofascial tension following scar release is proportional to the degree 
of the “biting” sensation felt while undermining the scar. With experience, it will 
become apparent that some scars hold emotions related to the traumatic event when 
the scar occurred [108]. Release of traumatic scars can induce some remarkable, 
involuntary patient emotional responses. Patients need to be pre-warned about 
this possible experience. The patient may maintain composure during the clinical 
encounter, but subsequently report that the emotional release occurred minutes or 
hours after the treatment.
3.1.11 Needling MTPs technique
Palpation of the targeted tissue, based on the core BASE tests, will provide the clinician 
with the relevant tissue to release. It is important to release this tissue at the most painful 
palpable pain point. Skin antisepsis prior to needling will be dictated by the clinician’s 
institutional policy. Needle selection depends on the site to be treated but usually requires 
a 30-gauge 25 mm or a 25-gauge 50 mm hollow-bore needle connected to a syringe of 
0.9% normal saline.
Common responses to trigger point activation (release) reported by patients 
include pain reduction, pain resolution, movement of the pain from the original 
site, pain with needle insertion, “biting” (especially with significant scars), burning 
(presumed blood flow into a released muscle), muscle twitch, muscle relaxation, 
release of tension, or shooting pain down a limb (not related to needling of an 
adjacent nerve). All these sensations are positive therapeutic symptoms and merit 
acknowledgement. In the uncommon instance where needling results in a muscle 
spasm, additional needle insertions are indicated to activate more trigger points.
3.1.12 Tips and tricks to help with tolerating needling techniques
Breathing techniques and other appropriate non-pharmacological techniques should 
also be utilized to distract from the needling process [140–142]. At all times, the clini-
cian must observe the patient for any signs of potential light-headedness/presyncope.
3.1.13 Catenated cycles
Catenated cycles (Figure 6) are repeated sequences of BASE testing, palpation, 
and needling in each session to unravel the multiple sites of anatomical distortion 
contributing to chronic pain. This is an important process as chronic pain, particu-
larly when it has been persistent for years or decades, results from multiple sites or 
contributors to the pain pattern. Catenated cycles assist in identifying the various 
contributing tissues to the larger pain pattern. Each cycle usually identifies the next 
new and different most painful or restrictive BASE test resulting in a new area of 
treatment. Poor results from myoActivation will result from only performing an 
initial series of BASE tests to find a starting point for treatment and then needling 
many tissues without undertaking the catenated cycles.
Catenated cycles demonstrate to the clinician some or all of the following visible 
changes in patient movement: increase in joint range, greater range of motion, 
increase in speed of movement, increase in ease, smoothness, or fluidity of move-
ment. This provides immediate feedback on treatment.
For the patient, catenated cycles will demonstrate some or all of the following 
subjective changes in post-treatment movement: reduction in overall perceived pain 
at rest and/or in movement, reduction or a diffusion in the area of pain, shift in pain 
location, perception of pain only at end range rather than throughout the range, or a 
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different pain focus altogether at a different location that only becomes perceptible 
when the initial painful site has been treated. Another advantage of the catenated 
cycles is that the patient has to get up and move after each treatment, which dis-
tracts from any pain resulting from the treatment process.
3.1.14 When to stop
It is optimal to end sessions at a successful end-point. These might include reso-
lution of pain, reduction in pain, improved flexibility, increased fluidity of move-
ment, positive postural changes, or change in the weight distribution of the feet to 
being more grounded (even plantar weight distribution). Otherwise, the decision 
during treatment to stop further needle insertions is a clinical judgement that is 
dictated primarily by the patient’s ability to tolerate the procedure. Fatigue and feel-
ing overwhelmed are not uncommon responses especially during the first treatment 
session. Despite receiving written consent, it is always advisable to request ongoing 
verbal consent at the appropriate times to ensure the patient is agreeable with ongo-
ing care. An important principle is not to do too much at each session.
3.1.15 Risks
In general, there are very few significant risks associated with myoActivation. 
Most common are bruising and short-term muscle pain. The most significant, but 
extremely rare complication is potential for a pneumothorax. All clinicians needling 
in the neck and thoracic region must be aware of the preventative strategies, and the 
symptoms and signs of pneumothorax. Written information should be supplied to 
patients detailing: what symptoms to notice, and the contact numbers for help and 
an algorithm of appropriate actions if these symptoms occur once the patient has 
left a clinical area.
Potential side effects of myoActivation include: sweating, light-headedness/ 
presyncope, pain from needle insertion, hematoma, muscle spasm, nausea, vomit-
ing, syncope, post-treatment muscle pain [146], pneumothorax, infection, and 
failure to respond.
Figure 6. 
Catenated cycles, unravelling pain.
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3.1.16 myoActivation after-care
Instructions following treatment are directed to promote recovery of treated 
tissues and prevent symptom regression. Patients are advised to move regularly, 
with frequent changes in posture (every 10–15 minutes) while awake in the first 
24–48 hours after each treatment. They are also advised to avoid myofascial load-
ing, repetitive exertion, and prolonged postures for 5 days. After this time, they 
can start graduated activity. The post-treatment response will be an individualized 
experience for each patient. Multiple factors will govern the outcome resulting from 
treatment including: degree of sedentary activity in daily life, physical demands in 
the workplace, patient age, genetically determined responsiveness of soft tissues, 
and the psychosocial factors related to chronic pain.
3.1.17 Number of sessions
It is optimal to schedule 2–3 sessions, 1 or 2 weeks apart, to minimize the need to 
do too much at each session, minimize pain following therapy and to help determine 
responsiveness. After three sessions, the clinician can determine if there is suf-
ficient positive response to continue. There is a wide range in numbers of sessions 
required in positive responders.
3.1.18 Concurrent therapy
Chronic pain is a complex biopsychosocial problem. myoActivation is just one 
component of a multidisciplinary care. Most patients benefit from concurrent treat-
ment in collaboration with other health professionals knowledgeable in treatment 
of patients living with chronic pain.
4. Case studies
Three cases are presented. Patients 1 and 2 were seen by a family physician with 
a focused practice in chronic pain exclusively employing myoActivation. Patient 3 
received care from a paediatric pain physician. Assessment and treatment for all 
cases primarily involved application of the myoActivation methodology.
4.1 A 31-year-old male with right sciatic and low back pain
A 31-year-old labourer was referred by his family physician for management of 
back and right lower extremity pain. He was not using regular prescription analge-
sia medications, but used occasional ibuprofen and marijuana. He had been dealing 
with intermittent lower back pain since he was 15.
Eight months prior to this assessment, he “pinched a nerve on the left side 
of this body” while lifting a granite countertop. He was off work for 1 month, 
participated in a return to work program, and was judged fit for work. He did 
not feel ready to return to physical labour and took 3 months off. At the end of 
this period (2 months before this visit), he experienced a pinching sensation 
in the right buttock while sitting. The symptoms progressed to “sciatic pain” in 
his upper back radiating to the right knee. These symptoms dissipated but he 
presented with episodic excruciating pain in the right upper buttock radiating 
down the right leg. The pain was precipitated by standing, going up stairs, or 
starting to walk. He had no symptoms of motor weakness, saddle numbness or 
urinary dysfunction.
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TiLT revealed a laceration to the right upper lip from a shovel at age 6 requiring 
stitches, multiple sutured lacerations on hands from work as a chef and a chicken 
pox scar on right upper lip. He sustained a right ankle injury from a snowboarding 
injury aged 15. He had snowboarded for 21 years prior to his work-related back 
injury but felt that he would never be able to snowboard again.
Past medical history included a 12-year history of depression with frequent 
suicidal ideation. Current antidepressant medications include bupropion and 
escitalopram.
Worst BASE test in terms of limited ROM and pain was flexion arms down.
On the principle of not doing too much especially on the first visit, it was deemed 
appropriate to stop at this time. Over the course of the next 28 days, the patient was 
seen three times to manage ever diminishing right-sided back and leg pains. Right-
sided jaw and neck pains became more prominent in the patient’s symptomatology 
with resolution of his back pain. myoActivation principles and process were followed 
using core and regional BASE tests to resolve these issues as well.
On visit 5, 51 days after initial assessment, the patient stated he was doing really 
well. Nothing was really troubling him although he was a bit stiff after snowboard-
ing 2 days previously. He remarked his hamstrings were tight, but he was working 
on stretching them every day and doing some yoga. He did, however, snowboard 
for a half-day and then a full day. He told himself he would go easy, but was able to 
snowboard without limitation. He reported that to have the confidence in his body 
and be able to snowboard was important for him as it was very meditative and his 
escape. His also reported that his mood had significantly improved. No treatment 
was necessary on this visit and the patient was discharged.
Standing posture findings
Pain focus No pain at rest while standing
Postural assessment Feet, no abnormality detected (NAD)
Knees level, hips level
No pelvic rotation or tilt, no torso shift
Left shoulder elevated
Head NAD
Plantar weight distribution Equal weight on feet, lateral edges, central
BASE testing
Extension arms raised Normal range of motion (ROM), pain low back
Extension arms down Normal ROM with no pain
Flexion arms down Limited ROM, pain low back, right more than left
Squat arms down Normal ROM with no pain
Squat arms raised Normal ROM with no pain
Treatment
Trigger point injections Right gluteus maximus at origin
Post-treatment assessment Normal ROM in flexion arms down
Patient quotes “I am not feeling any pain. It feels nice.”
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4.2 A 42-year-old female with fibromyalgia and chronic fatigue syndrome
4.2.1 Visit 1
A 42-year-old hospital kitchen worker was referred by her family physician for 
fibromyalgia and chronic fatigue syndrome. She had been receiving out-patient 
care (assessment, investigations (MRIs, X-rays, bone scan) and therapy) through a 
hospital-based complex chronic diseases programme. She had completed an online 
programme for pain self-management strategies at a local university, which she 
found tremendously helpful.
The patient described the onset of pain symptoms 15 years previously 
following a tooth extraction with subsequent infection. She had a pain and 
fatigue crisis 3 years previously from which she was unable to get out of bed for 
4 months. She reported that currently she has had widespread symptoms includ-
ing; gastrointestinal upset, brain fog, left temporomandibular joint dysfunction, 
nerve issues, right-sided migraines, central posterior neck pain, and bilateral 
scapular pain, left greater than right. A diagnosis of fibromyalgia and chronic 
fatigue syndrome was made 2 months prior to this visit. She is on long-term 
disability.
TiLT revealed that at age 10, she had been launched over the handle bars of her 
bicycle breaking an upper front tooth. Again, at age 10, she fell onto her tailbone 
requiring her to sit on a donut for a prolonged time after injury. At age 11, she 
rode a bike that was too big for her and injured her right knee from repetitive 
movement. She had bilateral knee scars from childhood injuries, right forearm 
burns from cooking, and a scar from a cut in the mid back from an exploding 
soda bottle, aged 12.
Past medical history revealed that she had had previous surgeries including 
dental and a lower segment C-section (LSCS). The patient reported post traumatic 
stress disorder related to severe pain during her LSCS due to inadequate analgesia 
from her epidural. Other relevant past medical issues included Hashimoto’s thy-
roiditis, postural orthostatic tachycardia syndrome, irritable bowel syndrome, and 
fibromyalgia.
4.2.1.1 Catenated cycle 1
The TiLT identified a significant tailbone injury in childhood. Clinical 
experience has demonstrated that tethering of soft tissues overlying the 
coccyx results in a significant biomechanical distortion. Therefore, in this case 
the first test indicated is sacrococcygeal palpation.
Current medications Synthroid, naltrexone, acetaminophen with codeine
Standing posture findings
Pain focus Left scapula
Postural assessment Feet NAD
Knees level, hips level
No pelvic rotation or tilt, no torso shift
Right shoulder elevated
Head NAD
Plantar weight distribution More weight on left foot, medial sides, heels
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4.2.1.2 Catenated cycle 2
4.2.1.3 Catenated Cycle 3 and Cycle 4
The straight-arm pinch BASE test specifically assesses restriction in scapular 
mobility from sustained contraction of the ipsilateral serratus anterior muscle.
4.2.1.4 Post-treatment assessment
Decreased lower back pain and left posterior shoulder pain. Increased ease 
and range in flexion arms down, extension arm raised, extension arms down, and 
straight-arm pinch.
BASE testing
Extension arms raised Severe ROM limitation with left shoulder pain
Extension arms down Moderate ROM limitation, left shoulder pain
Flexion arms down Moderate ROM limitation with pain lower back
Squat arms down Moderate ROM limitation with pain calves
Squat arms raised Severe ROM limitation with pain thighs
Palpation findings Palpable pain points C5-T11, left more than right
Treatment Bilateral paraspinals from C6 to T12
Extension arms raised Mild ROM limitation with left shoulder pain
Extension arms down Moderate ROM limitation with left shoulder pain
Flexion arms down Moderate ROM limitation with pain lower back
Squat arms down Moderate ROM limitation with pain calves
Squat arms raised Moderate ROM limitation with pain thighs
Straight arm pinch Limited range in left shoulder
BASE testing
Palpation findings Exquisitely tender in midline over coccyx
Treatment Fascia over coccyx
BASE testing
Extension arms raised Severe ROM limitation with left shoulder pain
Extension arms down Moderate ROM limitation, left shoulder pain
Flexion arms down Moderate ROM limitation with pain lower back
Squat arms down Moderate ROM limitation with pain calves
Squat arms raised Severe ROM limitation with pain thighs
Palpation findings Palpable pain points C5-T11, left more than right
Treatment Bilateral paraspinals from C6 to T12
Palpation findings Palpable densities overlying left ribs 4–6 between anterior and 
posterior axillary lines
Treatment Left serratus anterior
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4.2.1.5 Patient quotes
“That’s crazy!” “I feel so light!”
4.2.2 Visit 2 (7 days after visit 1)
The patient reported she had had a rough week, with soreness and pain for about 
5 days, especially from the injection over the coccyx. She felt her pain pattern was 
different. She felt lighter but was still feeling brain fog. The left shoulder blade felt 
stiff but not painful.
4.2.2.1 Catenated cycle 1
4.2.2.2 Post-treatment assessment
Decreased brain fog. Increased ease in ambulation.
4.2.3 Visit 3 (14 days after visit 1)
She has not had any pain in her neck or shoulder. Right knee was biggest 
problem.
Standing posture findings
Pain focus Head pressure
Postural assessment Feet NAD
Knees’ level, hips’ level
No pelvic rotation or tilt, no torso shift
Shoulders’ level
Head NAD
Plantar weight distribution Equal weight on feet, medial sides, heels
BASE testing
Extension arms raised Mild ROM limitation with pain lower back
Extension arms down Moderate ROM limitation with pain lower back
Flexion arms down Normal ROM with no pain
Squat arms down Normal ROM with no pain
Squat arms raised Normal ROM with no pain
Treatment C-section scar
Standing posture findings
Pain focus standing No pain at rest while standing
Postural assessment Feet NAD
Knees’ level, hips’ level
No pelvic rotation or tilt, no torso shift
Shoulders’ level
Head NAD
Plantar weight distribution Equal weight on feet, central, balls of feet
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4.2.3.1 Catenated cycle 1
4.2.3.2 Catenated cycle 2
[The lateral arch BASE test specifically assesses restriction in pelvic mobility from 
sustained contraction of the ipsilateral iliopsoas muscle].
4.2.3.3 Post-treatment assessment
Decreased lower back and flank pain. Increased ease in ambulation, extension 
arms raised, extension arms down, and lateral arches.
4.2.4 Visit 4 (50 days after visit 1)
She had a lot more mobility since the last visit with no significant pain other than 
the right knee. She had not had a migraine in several weeks.
4.2.4.1 Catenated cycle 1
BASE testing
Extension arms raised Moderate ROM limitation with fatigue in right lower back
Extension arms down Severe ROM limitation with fatigue in right lower back and neck
Flexion arms down Limited ROM with pain in low back
Squat arms down Normal ROM with no pain
Squat arms raised Normal ROM with no pain
Palpation findings Palpable tender density in right external oblique muscle 
medial to anterior superior iliac spine (ASIS)
Treatment Right external oblique
BASE testing
Right lateral arch Mild ROM limitation with right low back pain
Left lateral arch Mild ROM limitation with hip tension
Palpation findings Exquisite tenderness to light palpation of the right iliopsoas 
tendon in the femoral triangle
Treatment Right iliopsoas
Standing posture findings
Pain focus standing Right knee
Plantar weight distribution Equal weight on feet, medial sides, heels
BASE testing
Extension arms raised Moderate ROM limitation, pain in quadriceps
Extension arms down Moderate ROM limitation, pain in right knee
Flexion arms down Normal ROM with no pain
Squat arms down Normal ROM with no pain
Squat arms raised Normal ROM with no pain
Palpation findings Palpable tenderness and density in right external oblique 
inferomedial to ASIS
Treatment Right external oblique
23
myoActivation: A Structured Process for Chronic Pain Resolution
DOI: http://dx.doi.org/10.5772/intechopen.84377
4.2.4.2 Post-treatment assessment
Decreased right knee pain. Increased range in extension arms raised, extension 
arms down, and lateral arch BASE tests as well as ease in ambulation.
4.2.5 Follow-up (294 days after visit 1)
The patient reported significant improvement in all her symptoms. Previous 
blinding aura migraines occurring 2–3/week were now reduced to mild aura 
migraines 1–2/month. She had full resolution of her neck pain at the base of her 
skull (pain previously scored at 7–10/10), her coccygeal pain (previously 2–4/10), 
and hip pain (previously 6–8/10). She reported significant reductions in her left 
scapular pain (previously 6–8/10, now 2–6/10) and right knee pain (previously 
4–7/10, now 2–4/10). She was also experiencing improved cognitive function, 
improved focus and reduced sensitivity to light and sound.
4.3 Paediatric case study: low back pain
A 4-year-old girl was referred to a paediatric complex pain clinic by her neu-
rosurgeon with a 2-year history of low back pain. Her mother reported that her 
daughter’s pain started approximately 1 month following lumbosacral dermal 
sinus tract surgery. There had been no obvious pain prior to surgery. Her pain was 
focused in the midline from level of T12 to sacrum. The pain was variable but worse 
towards end of day, early evening, and night-time. The pain was associated with 
her being “cranky and irritable”. Relief was gained with heat, necessitating many 
hours per day in a warm bath. The pain was aggravated by swimming, sitting and 
cold weather, but there were no issues with walking. The pain was not relieved by 
acetaminophen or ibuprofen. There were no scoliosis, no motor deficits, and no 
urinary or bladder issues.
In the past medical history, there had been no motor vehicle accidents, no 
fractures or other trauma, no falls on the coccyx/tailbone, and no other surger-
ies. The only scar was that related to her dermal sinus surgery. In response to 
the question “What has been her greatest physical trauma?” the answer was her 
dermal sinus surgery with a minor delayed healing of a part of the wound. The 
child was born at term by normal spontaneous vaginal delivery following a nor-
mal pregnancy. There were no other health issues, no allergies, and no current 
medications.
The lumbosacral dermal sinus tract excision surgery was uncomplicated, 
followed by an uneventful recovery and discharge from hospital 3 days postopera-
tively. Recent investigations included blood work, X-rays, and an MRI of the spine: 
all reported to be normal. Neurological, neurosurgical, and orthopaedic consulta-
tions revealed no abnormality to explain her ongoing pain.
The child was 22 kg and very active and clingy to her mother. She was 
reluctant to be examined, but interestingly was keen to participate in the core 
BASE tests as long as she was copying her mum. Pain site was as reported in the 
history.
Standing posture findings
Pain focus Low back
Postural assessment Hips level, shoulders level
Plantar weight distribution Patient unable to differentiate
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The worst BASE test in terms of limited ROM and pain was EAR and FAD.
It was not possible to determine the weight distribution on the feet. The core 
BASE tests that appeared to be most restricted were EAR and FAD; the most painful 
of these was EAR. The child was able to perform the other core BASE tests with no 
apparent difficulty. The surgical scar over her sacral area was well healed, but the 
mid portion of it had a 2-cm wider part that had presumably been the site of the 
reported delayed healing. There was no tenderness over the coccyx.
The examination revealed no obvious abnormality other than the scar in the 
midline and a right paraspinal muscle in sustained contraction.
The child was started on magnesium bisglycinate, vitamin K2, and vitamin D3. 
Three weeks later, scar release and right paraspinal release were performed under 
general anaesthesia. At follow-up, 4 months after initial assessment, the child was 
pain free and active in dance.
5. Discussion
5.1 How does myoActivation work?
myoActivation is a process that enables the clinician to connect or link the 
patient’s TiLT with the myofascial findings on examination. The targeted myofascial 
activations appear to restore the biomechanical, neuroendocrine, and autonomic 
balance to reduce chronic pain. Research is required to determine which compo-
nents of the myofascial system are really important in making the observed changes 
seen following myoActivation.
5.2 What makes myoActivation different?
A distinctive and foundational principle of myoActivation is  that the perceived 
site of pain is often not the source of pain. myoActivation constitutes a paradigm shift 
in how to take a pain history and examine a patient with chronic pain.
The history focuses on a TiLT, including surgery, motor vehicle accidents, 
fractures, scars, and injuries. It highlights the importance of scars as contributors 
to chronic pain, especially scars inflicted at a young age or associated with poor 
healing. It relies on excellent clinical acumen to observe postural abnormalities and 
skeletal asymmetries, and to locate palpable painful points that help guide therapy 
as illustrated in the cases presented.
Standard structured BASE tests are used to distinguish significant fascial or 
muscle trigger point contributors to chronic pain. This structured assessment 
and treatment is reproducible and therefore a unique framework to perform 
comparative research. A synthesis of pertinent findings connects the dots that link 
the patient’s TiLT with the myofascial findings, looking at the patient as a whole 
biomechanical structure and not as segmented symptomatic parts.
Needling is performed with hollow bore needles, with a cutting tip, which is utilized 
to target and release scars, fascia in tension and PPPs in muscles; therefore, it is not the 
BASE testing
Extension arms raised Mildly ROM with pain low back
Extension arms down Normal ROM with no pain
Flexion arms down Limited ROM with pain low back, right greater than left
Squat arms down Normal ROM with no pain
Squat arms raised Normal ROM with no pain
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same as classical intramuscular stimulation (IMS), traditional Chinese acupuncture, 
western medicine acupuncture, prolotherapy, or dry needling targeted at the site of pain. 
Immediate changes occur such as decreased pain, improved flexibility and improved 
fluidity of movement, which are easily demonstrated with the repetition of BASE tests.
Even if a needling technique is not used, for example in children or in individu-
als with needle aversion, the myoActivation TiLT, assessment, and examination can 
be used to determine if there is a myofascial component to chronic pain and direct 
patients to non-needling therapies such as physiotherapy and massage.
myoActivation uses catenated cycles of intervention and reassessment of baseline 
tests to unravel the important muscle groups and fascial tensions contributing to 
the particular pain problem, then repeats baseline tests to highlight the next bio-
mechanically significant tissue in tension. It typically requires 2–5 myoActivation 
sessions to get to the treatment goal of improved flexibility and reduced pain or 
resolution of pain.
myoActivation can be used to reduce pain in different pain populations for a vari-
ety of different pain conditions. It can cause an emotional release, fatigue, sense of 
lightness, or well-being at the time of myoActivation. It restores hope to patients as it 
provides an answer to the cause of years of pain. It provides a tool in the toolbox for 
clinicians, which is low cost, effective, and does not require specialized equipment 
or imaging. It can be easily incorporated into primary care practice and, therefore, 
not subject to tertiary care waitlists. However, to be effective, it does need to be 
applied by an appropriately trained clinician.
myoActivation as an effective tool means the clinician does not have to rely on 
pharmaceutical analgesic agents for myofascial pain. Pain resolution and its effects 
on improved function, and ultimately mood, enables weaning of established 
analgesia medications, including opioid medications.
5.3 What is the future of myoActivation?
With its low cost and no requirement for resource-intensive clinical investiga-
tions, myoActivation has the potential to support the movement for “winding back 
the harms of too much medicine” [147]. However, for that to happen, we need to 
develop programmes of research and training and to address the barriers of awareness, 
availability, and accessibility [43].
Demonstrating a firm evidence base for the perceived benefits of myoActiva-
tion will ultimately require prospective research studies, including multi-centre 
clinical trials [148]. Many questions remain about mechanism of action, spe-
cific approaches in different populations, benefits of integration with other 
therapeutic techniques, timing of myoActivation, and integration with other 
management techniques. In the meantime, we must rely on patient voices, case 
studies, audit through patient registries (where myoActivation has been delivered 
by accredited personnel), population–based, case-controlled studies [149] and 
N-of-1 studies, especially considering the diversity of chronic pain presentations 
in the population [150].
Clinicians will need to be trained in the art of determining palpable pain points 
and to learn myoActivation before they can fully incorporate this process into their 
everyday practice. A core group of myoActivation faculty, led by Dr. Siren, is devel-
oping a programme for training and dissemination of myoActivation. Assessment 
and treatment strategies often begin as local initiatives and are developed into widely 
accepted standards for care; for example, Managing Emergencies in Paediatric 
Anaesthesia started in one centre in the UK [151], but is now an internationally rec-
ognized course teaching a standard approach worldwide [152, 153]. Other examples 
include Advanced Cardiac Life Support and Advanced Paediatric Life Support [154].
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6. Conclusion
In the face of the burden of chronic pain, including its economic impact, it is 
imperative to establish new and effective tools to minimize the impacts of this con-
dition. Early intervention is key to success in managing chronic pain. This requires 
that a tool be available, accessible, and affordable to community clinicians. The 
current opioid crisis and limited therapeutic effectiveness of many pharmaceutical 
agents in chronic pain necessitate a different approach.
This chapter has described the core assessment and therapeutic process of a 
novel technique to manage myofascial components of chronic pain. myoActivation 
is structured and reproducible, with a high benefit to risk ratio. It can be applied to 
many different chronic pain presentations and different age groups.
Clinicians will need to be trained to successfully incorporate core and regional 
components of myoActivation into their practice. We hope that this chapter will be 
an incentive for clinicians to learn more about this system of care. It is clear from 
experience that this is an effective approach and brings a much-needed tool into 
the toolbox for chronic pain, which, so far, has evaded an efficacious therapeutic 
modality.
“In departing from any settled opinion or belief, the variation, the change, the 
break with custom may come gradually; and the way is usually prepared; but the 
final break is made, as a rule, by some one individual, […] who sees with his own 
eyes, and with an instinct or genius for truth, escapes from the routine in which his 
fellows live.”
      Sir William Osler, 1849–1919.
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